Paxlovid™ Nirmatrelvir / Ritonavir 300 mg - 150 mg / 100 mg Tablet 11 Tablets

Features

• PAXLOVID is indicated for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults who are at high risk for progression to severe COVID-19
• PAXLOVID is not approved for use as pre-exposure or post-exposure prophylaxis for prevention of COVID-19
• 300 mg nirmatrelvir; 100 mg ritonavir (Day 1)
• 150 mg nirmatrelvir; 100 mg ritonavir (Days 2-5)